NFKB1 and temporal lobe epilepsy: Moreover, BUT reduced the expression of the inflammatory factor NFκB, a marker of nervous tissue dysregulation that resulted in increased hippocampus of patients with temporal lobe epilepsy (Teocchi et al., 2013).